Although long recognised as a xenobiotic sensing receptor, the Aryl Hydrocarbon Receptor (AHR) is now known to inhibit tumour development, partly because of its regulation of innate immune surveillance and response mechanisms. The gene discussed is AHR; the disease is neoplasm.